RESUMEN
Current strategies for predicting adverse health outcomes of environmental chemicals are centered on early key events in toxicity pathways. However, quantitative relationships between early molecular changes in a given pathway and later health effects are often poorly defined. The goal of this study was to evaluate short-term key event indicators using qualitative and quantitative methods in an established pathway of mouse liver tumorigenesis mediated by peroxisome proliferator-activated receptor alpha (PPARα). Male B6C3F1 mice were exposed for 7 days to di (2-ethylhexyl) phthalate (DEHP), di-n-octyl phthalate (DNOP), and n-butyl benzyl phthalate (BBP), which vary in PPARα activity and liver tumorigenicity. Each phthalate increased expression of select PPARα target genes at 7 days, while only DEHP significantly increased liver cell proliferation labeling index (LI). Transcriptional benchmark dose (BMDT) estimates for dose-related genomic markers stratified phthalates according to hypothetical tumorigenic potencies, unlike BMDs for non-genomic endpoints (relative liver weights or proliferation). The 7-day BMDT values for Acot1 as a surrogate measure for PPARα activation were 29, 370, and 676 mg/kg/day for DEHP, DNOP, and BBP, respectively, distinguishing DEHP (liver tumor BMD of 35 mg/kg/day) from non-tumorigenic DNOP and BBP. Effect thresholds were generated using linear regression of DEHP effects at 7 days and 2-year tumor incidence values to anchor early response molecular indicators and a later phenotypic outcome. Thresholds varied widely by marker, from 2-fold (Pdk4 and proliferation LI) to 30-fold (Acot1) induction to reach hypothetical tumorigenic expression levels. These findings highlight key issues in defining thresholds for biological adversity based on molecular changes.
Asunto(s)
Neoplasias Hepáticas Experimentales/inducido químicamente , PPAR alfa/fisiología , Animales , Benchmarking , Peso Corporal/efectos de los fármacos , Proliferación Celular , Dietilhexil Ftalato/toxicidad , Relación Dosis-Respuesta a Droga , Modelos Lineales , Hígado/metabolismo , Hígado/patología , Masculino , Ratones , Estrés Oxidativo , Ácidos Ftálicos/toxicidad , Reacción en Cadena de la PolimerasaRESUMEN
Organophosphate flame retardants (OPFRs) are common replacements for the phased-out polybrominated diphenyl ethers (PBDEs) and have been detected at high concentrations in environmental samples. OPFRs are structurally similar to organophosphate pesticides and may adversely affect the developing nervous system. This study evaluated the overt toxicity, uptake, and neurobehavioral effects of tris (1,3-dichloro-2-propyl) phosphate (TDCPP), tris (2-chloroethyl) phosphate (TCEP), tris (1-chloro-2-propyl) phosphate (TCPP), and tris (2,3-dibromopropyl) phosphate (TDBPP) in early life stage zebrafish. Chlorpyrifos was used as a positive control. For overt toxicity and neurobehavioral assessments, zebrafish were exposed from 0 to 5 days postfertilization (dpf). Hatching, death, or malformations were evaluated daily. Teratogenic effects were scored by visual examination on 6 dpf. To evaluate uptake and metabolism, zebrafish were exposed to 1 µM of each organophosphate (OP) flame retardant and collected on 1 and 5 dpf to monitor accumulation. Larval swimming activity was measured in 6 dpf larvae to evaluate neurobehavioral effects of exposures below the acute toxicity threshold. TDBPP elicited the greatest toxicity at >1 µM. TDCPP and chlorpyrifos were overtly toxic at concentrations ≥10 µM, TCEP, and TCPP were not overtly toxic at the doses tested. Tissue concentrations increased with increasing hydrophobicity of the parent chemical after 24 h exposures. TDCPP and TDBPP and their respective metabolites were detected in embryos on 5 dpf. For all chemicals tested, developmental exposures that were not overtly toxic significantly altered larval swimming activity. These data indicate that OPFRs adversely affect development of early life stage zebrafish.
Asunto(s)
Anomalías Inducidas por Medicamentos , Conducta Animal/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Retardadores de Llama/toxicidad , Organofosfatos/toxicidad , Pez Cebra/crecimiento & desarrollo , Anomalías Inducidas por Medicamentos/etiología , Anomalías Inducidas por Medicamentos/psicología , Animales , Relación Dosis-Respuesta a Droga , Embrión no Mamífero/efectos de los fármacos , Retardadores de Llama/farmacocinética , Estructura Molecular , Sistema Nervioso/efectos de los fármacos , Sistema Nervioso/embriología , Organofosfatos/química , Organofosfatos/farmacocinética , Análisis de Supervivencia , Natación , Pez Cebra/embriología , Pez Cebra/metabolismoRESUMEN
Given the minimal developmental neurotoxicity data available for the large number of new and existing chemicals, there is a critical need for alternative methods to identify and prioritize chemicals for further testing. We outline a developmental neurotoxicity screening approach using zebrafish embryos. Embryos were exposed to nominal concentrations of either valproate or ethanol then examined for lethality, malformation, nervous system structure and locomotor activity. Developmental valproate exposure caused locomotor activity changes at concentrations that did not result in malformations and showed a concentration-dependent decrease in retino-tectal projection area in the optic tectum. Developmental ethanol exposure also affected retino-tectal projection area at concentrations below those concentrations causing malformations. As both valproate and ethanol are known human developmental neurotoxicants, these results add to the growing body of evidence showing the potential utility of zebrafish in screening compounds for mammalian developmental neurotoxicity.
Asunto(s)
Embrión no Mamífero/efectos de los fármacos , Etanol/toxicidad , Retina/efectos de los fármacos , Teratógenos/toxicidad , Ácido Valproico/toxicidad , Pez Cebra , Anomalías Inducidas por Medicamentos , Animales , Embrión no Mamífero/embriología , Actividad Motora/efectos de los fármacos , Retina/patología , Colículos Superiores/efectos de los fármacos , Colículos Superiores/patología , Pruebas de Toxicidad/métodosRESUMEN
The potential use of hypothermia as a therapeutic treatment for stroke and other pathological insults has prompted the search for drugs that can lower core temperature. Ideally, a drug is needed that reduces the set-point for control of core temperature (T(c)) and thereby induces a regulated reduction in T(c). To this end, a neurotensin analog (NT77) that crosses the blood brain barrier and induces hypothermia was assessed for its effects on the set-point for temperature regulation in the Sprague-Dawley rat by measuring behavioral and autonomic thermoregulatory responses. Following surgical implanation of radiotransmitters to monitor T(c), rats were placed in a temperature gradient and allowed to select from a range of ambient temperatures (T(a)) while T(c) was monitored by radiotelemetry. There was an abrupt decrease in selected T(a) from 29 to 16 degrees C and a concomitant reduction in T(c) from 37.4 to 34.0 degrees C 1 hr after IP injection of 5.0 mg/kg NT77. Selected T(a) and T(c) then recovered to control levels by 1.5 hr and 4 hr, respectively. Oxygen consumption (M) and heat loss (H) were measured in telemetered rats housed in a direct calorimeter maintained at a T(a) of 23.5 degrees C. Injection of NT77 initially led to a reduction in M, little change in H, and marked decrease in T(c). H initially rose but decreased around the time of the maximal decrease in T(c). Overall, NT77 appears to induce a regulated hypothermic response because the decrease in T(c) was preceded by a reduction in heat production, no change in heat loss, and preference for cold T(a)'s. Inducing a regulated hypothermic response with drugs such as NT77 may be an important therapy for ischemic disease and other insults.
Asunto(s)
Hipotermia/inducido químicamente , Neurotensina/farmacología , Animales , Metabolismo Basal/efectos de los fármacos , Temperatura Corporal/efectos de los fármacos , Regulación de la Temperatura Corporal/efectos de los fármacos , Calorimetría , Hipotermia/fisiopatología , Masculino , Neurotensina/análogos & derivados , Consumo de Oxígeno/efectos de los fármacos , Ratas , Ratas Sprague-DawleyRESUMEN
INTRODUCTION: Measurement of tail skin temperature (T(sk)) of the rat can provide important information on mechanisms pertaining to physiology, pharmacology, and toxicology. T(sk) is largely under control of peripheral vascular tone, which is also sensitive to most experimental manipulations such as handling and restraint. Hence, it is extremely difficult to acquire long-term measurements of T(sk) that are free of artifacts from experimental manipulation. The purpose of this study is to demonstrate the utility of a radiotelemetric probe to provide continuous, long-term measurements of T(sk) in undisturbed rats. METHODS: A telemetry probe is placed on the base of the tail and secured with a protective guard to prevent the rat from chewing on the probe. T(sk) is continuously monitored with standard radiotelemetric software and computer technology. Core temperature (T(c)) is monitored in duplicate sets of rats at the same time but the current system does not allow for simultaneous measurement of T(sk) and T(c) from the same animal. Rats were subjected to a variety of experimental manipulations to demonstrate the utility of the probe. RESULTS/DISCUSSION: A marked increase in T(sk) was seen during the transition from light to dark phase, reflecting an increase in heat loss to lower T(c); a decrease in T(sk) during the development of endotoxin-induced fever, reflecting a reduction in heat loss to facilitate an elevation in T(c); an increase in T(sk) following exposure to the organophosphate insecticide chlorpyrifos, reflecting an increase in heat loss to facilitate a hypothermia response; and a direct effect of increasing ambient temperature on T(sk). The probe is relatively inexpensive and is used with no surgery and provides long-term measurement (e.g., >24 h) of T(sk) in unrestrained rats.
Asunto(s)
Temperatura Corporal , Fenómenos Fisiológicos de la Piel , Cola (estructura animal)/fisiología , Telemetría/métodos , Animales , Temperatura Corporal/efectos de los fármacos , Cloropirifos/farmacología , Ambiente , Insecticidas/farmacología , Lipopolisacáridos/farmacología , Ratas , Piel/irrigación sanguínea , Piel/efectos de los fármacos , Cola (estructura animal)/efectos de los fármacos , Factores de TiempoRESUMEN
Administration of the organophosphate pesticide chlorpyrifos (CHP) to the male rat at a dose of 25-80 mg/kg (p.o.) results in hypothermia followed by a delayed fever lasting for several days. These are high doses of CHP that cause marked cholinergic stimulation. It is important to understand if chronic exposure to CHP would evoke changes in thermoregulation that are comparable to the acute administration. Male rats of the Long-Evans strain were subjected to dietary treatment of 0, 1, or 5 mg/(kg day) CHP for 6 months. A limited amount of food was given per day to maintain body weight at 350 g. The constant body weight allowed for the regulation of a consistent dosage of CHP per kg body weight throughout the feeding period. Core temperature (T(a)) and motor activity (MA) were monitored by radio telemetric transmitters implanted in the abdominal cavity. After 5 months of treatment, T(c) and MA were monitored in undisturbed animals for 96 h. CHP at 5 mg/(kg day) led to a slight elevation in T(c) without affecting MA. The rats were then administered a challenge dose of CHP (30 mg/kg, p.o.) while T(c) and MA were monitored. Rats fed the 1 and 5 mg/kg CHP diets showed a significantly greater hypothermic response and reduction in MA following CHP challenge compared to controls. The restricted feeding schedule resulted in marked changes in the pattern of the circadian rhythm. Therefore, in another study, rats were treated ad libitum for 17 days with a CHP diet that resulted in a dosage of 7 mg CHP/(mg day). There was a significant increase in T(c) during the daytime but not during the night throughout most of the treatment period. Overall, chronic CHP was associated with a slight but significant elevation in T(c) and greater hypothermic response to a CHP challenge. This latter finding was unexpected and suggests that chronic exposure to CHP sensitizes the rat's thermoregulatory response to acute CHP exposure.